Twinbeech Capital LP Acquires Shares of 135,881 UnitedHealth Group Incorporated (NYSE:UNH)

Twinbeech Capital LP purchased a new position in UnitedHealth Group Incorporated (NYSE:UNH) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 135,881 shares of the healthcare conglomerate’s stock, valued at approximately $68,737,000. UnitedHealth Group accounts for 1.2% of Twinbeech Capital LP’s holdings, making the stock its 8th biggest position.

Several other hedge funds and other institutional investors have also recently modified their holdings of UNH. NewSquare Capital LLC bought a new position in UnitedHealth Group in the fourth quarter worth approximately $25,000. Marshall & Sterling Wealth Advisors Inc. bought a new position in UnitedHealth Group in the fourth quarter worth approximately $26,000. Hurley Capital LLC bought a new position in UnitedHealth Group in the fourth quarter worth approximately $28,000. AlphaMark Advisors LLC bought a new position in UnitedHealth Group in the fourth quarter worth approximately $30,000. Finally, Aster Capital Management DIFC Ltd bought a new position in UnitedHealth Group in the fourth quarter worth approximately $30,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Performance

Shares of UNH opened at $291.24 on Monday. The stock has a 50-day moving average of $470.82 and a two-hundred day moving average of $513.25. UnitedHealth Group Incorporated has a one year low of $248.88 and a one year high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The stock has a market cap of $264.20 billion, a P/E ratio of 18.79, a P/E/G ratio of 1.37 and a beta of 0.56.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). The company had revenue of $109.58 billion for the quarter, compared to analysts’ expectations of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same quarter in the previous year, the business posted $6.91 EPS. As a group, research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were paid a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 2.88%. UnitedHealth Group’s payout ratio is currently 35.18%.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, Director Kristen Gil purchased 3,700 shares of the business’s stock in a transaction that occurred on Thursday, May 15th. The stock was purchased at an average price of $271.17 per share, for a total transaction of $1,003,329.00. Following the purchase, the director now directly owns 3,818 shares in the company, valued at approximately $1,035,327.06. This trade represents a 3,135.59% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Stephen J. Hemsley purchased 86,700 shares of the business’s stock in a transaction that occurred on Friday, May 16th. The stock was acquired at an average price of $288.57 per share, with a total value of $25,019,019.00. Following the purchase, the chief executive officer now owns 679,493 shares in the company, valued at $196,081,295.01. This represents a 14.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last quarter, insiders purchased 109,408 shares of company stock worth $31,607,768. Insiders own 0.33% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have issued reports on UNH shares. Raymond James cut UnitedHealth Group from a “strong-buy” rating to a “market perform” rating in a research report on Wednesday, May 14th. Wells Fargo & Company dropped their target price on UnitedHealth Group from $677.00 to $351.00 and set an “overweight” rating on the stock in a research report on Wednesday, May 14th. Truist Financial dropped their target price on UnitedHealth Group from $660.00 to $580.00 and set a “buy” rating on the stock in a research report on Monday, April 21st. Mizuho dropped their target price on UnitedHealth Group from $515.00 to $350.00 and set an “outperform” rating on the stock in a research report on Friday. Finally, Hsbc Global Res cut UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, April 22nd. Six research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $486.00.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.